Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab

Clinical trial NCT04224636 · UNKNOWN

Trial details

NCT number: NCT04224636
Sponsor: Ludwig-Maximilians - University of Munich
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2020-06-10
Primary completion: 2025-03-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.